Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan *
Pharmacy Only: Prescription

Updated on 26 May 2022

File name

628f89e3bee2b.pdf

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - excipient warnings
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Updated on 26 May 2022

File name

628f88ff66e22.pdf

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
  • Change to section 6.1 - List of excipients
  • Change to section 6.5 - Nature and contents of container
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 05 October 2021

File name

ie-spc-MAHT-clean_1633421899.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 05 October 2021

File name

ie-pl-MAHT-clean_1633421859.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Updated on 28 July 2021

File name

emea-spc-h-4240-en (clean v017)_1627476321.pdf

Reasons for updating

  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

(Ref: EMEA/H/C/004240/IB/0017) Changes to the Summary of Product Characteristics and Package Leaflet to extend the PRAC conclusions from PSUSA on Metamizole (PSUSA/0001997/202003) to efavirenz-containing products

Updated on 28 July 2021

File name

Package leaflet (IE) - clean v017_1627476263.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink

Free text change information supplied by the pharmaceutical company

(Ref: EMEA/H/C/004240/IB/0017) Changes to the Summary of Product Characteristics and Package Leaflet to extend the PRAC conclusions from PSUSA on Metamizole (PSUSA/0001997/202003) to efavirenz-containing products

Updated on 27 April 2021

File name

Efavirenz Emtricitabine Tenofovir SPC_1619531540.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 27 April 2021

File name

Efavirenz Emtricitabine Tenofovir PIL_1619531493.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 24 February 2021

File name

emea-spc-clean (v013)_1614198905.pdf

Reasons for updating

  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 24 February 2021

File name

Package leaflet (IE) - clean v013_1614198867.pdf

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 6 - date of revision

Updated on 10 March 2020

File name

SmPC (IE only) (v009) - clean_1583842432.pdf

Reasons for updating

  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 10 March 2020

File name

Leaflet (IE-UK) (v009)- clean_1583842399.pdf

Reasons for updating

  • Change to section 5 - how to store or dispose
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 31 May 2019

File name

Package leaflet (v007 14May2019)- clean_1559157873.pdf

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 6 - marketing authorisation holder

Updated on 29 May 2019

File name

SmPC (v00714May2019)-clean_1559157950.pdf

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 20 July 2018

File name

Package leaflet (v001 17May2018).pdf

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product looks like and pack contents

Updated on 19 July 2018

File name

SUMMARY OF PRODUCT CHARACTERISTICS (v001 17May2018).pdf

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 03 July 2018

File name

SUMMARY OF PRODUCT CHARACTERISTICS (MAA Sep2017).docx

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 03 July 2018

File name

Package leaflet (MAA Sep2017).pdf

Reasons for updating

  • New PIL for new product